The arrival of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable buzz within the healthcare community. This groundbreaking dual GIP and GLP-1 agonist medication appears to provide impressive improvements in fat loss compared to current therapies. Early clinical data have sho